A team of researchers have discovered a key marker in blood and urine that identifies people who carry the DHDDS genetic mutation that is one of the genetic causes of retinitis pigmentosa. This breakthrough discovery means it will be much easier to test children for the disease which affects almost 1 in 4,000 people in […]
Jetrea, an intravitreal injection therapy which was previously approved by the FDA last October, has now gained approval for use in Europe. Jetrea is the only approved drug therapy used to treat vitreomacular traction (VMT). Vitreomacular traction causes holes in the macula, which then leads to irreversible vision loss. The macula is responsible for central […]
Some patients suffering from retinitis pigmentosa will benefit from the Food and Drug Administration’s approval of the Argus II Retinal Prosthesis System. It is the first treatment for the inherited eye disorder and will be available for patients who are 25 years and older who have the advanced form of the disease. Retinitis pigmentosa causes […]
The potential for developing a new treatment or cure for retinitis pigmentosa may be found through studying genetically modified pigs. Retinitis pigmentosa is the most common inherited retinal disease in the United States and affects about 1 in 4000 Americans. Previously, rodents were used in studies but their eyes lack some vital retinal structures and […]
Researchers have discovered that our eye health may be closely linked to our brain health. An increased risk for thinking and memory problems has been associated with retinopathy. Retinopathy occurs when the retina is damaged as a result of vascular disease. That same vascular disease may also cause damage to the brain. In a study […]
Recent findings have shown that a diet high in omega-3 fatty acids combined with vitamin A supplementation may slow vision loss for patients with retinitis pigmentosa.